您的位置: 首页 > 农业专利 > 详情页

AGENTS THÉRAPEUTIQUES CIBLÉS SUR L'APOE4 QUI ACCROISSENT SIRT1
专利权人:
The Regents of the University of California;Buck Institute for Research on Aging;Jagodzinska, Barbara;Campagna, Jesus;Pham, Johnny;Jung, Michael E.
发明人:
申请号:
EP15834442.4
公开号:
EP3183229A4
申请日:
2015.08.19
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
A link between ApoE4 allele and sirtuins expression level is identified that is believed to be associated with elevated risk for the promotion of processing of amyloid precursor protein (APP) by the non-amyloidogenic pathway in a mammal leading to elevated risk for Alzheimer's disease. Compounds are identified that upregulate sirtuins (e.g., SirT1) expression levels and appear to be useful in the treatment and/or prophylaxis of MCI and/or Alzheimer's disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充